|
Publications 2000
1 Regional differences in presentation of AIDS in Europe. Blaxhult A, Kirk O, Pedersen C, Dietrich M, Barton SE, Gatell JM, Mulcahy F, Hirschel B, Mocroft A, and Lundgren JD for the AIDS in Europe Study Group
Epidemiol Infect. 2000;125(1):143-151. abstract
2 Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus. Christensen JK, Eugen-Olsen J, Sørensen M, Ullum H, Gjedde SB, Pedersen BK, Nielsen JO, and Krogsgaard K
J Infect Dis.2000;181(5):1796-1799. abstract
3 Relapse of multiresistant Salmonella typhi after combined therapy with ciprofloxacin and ceftriaxone. Dragsted UB and Pedersen P
Clin Microbiol Infect. 2000;6(3):167-168. abstract
4 Aldesleukin Chiron Therapeutics. Dragsted UB and Lundgren JD.
Curr Opin Investig Drugs. 2000;2(3):323-331
5 [Treatment of HIV infections with antiretroviral drugs and recombinant interleukin-2]. Dragsted UB, Afzelius P, Nielsen SD, and Lundgren JD
Ugeskr Laeger. 2000;162(42):5614-5618. abstract
6 Effect of the serotonin receptor agonist, buspirone, on immune function in HIV-infected individuals: a six-month randomized, double-blind, placebo-controlled trial. Eugen-Olsen J, Benfield T, Axen TE, Parner J, Iversen J, Pedersen C, and Nielsen JO
HIV Clin Trials. 2000;1(1):20-26. abstract
7 Human immunodeficiency virus-associated malignant lymphoma in eastern Denmark diagnosed from 1990-1996: clinical features, histopathology, and association with Epstein-Barr virus and human herpesvirus-8. Hansen PB, Penkowa M, Kirk O, Skinhoj P, Pedersen C, Lisse I, Kiss K, Zhou X, and Hamilton-Dutoit SJ
Eur J Haematol. 2000;64(6):368-375. abstract
8 Rapid detection of dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restriction fragment length polymorphism. Helweg-Larsen J, Eugen-Olsen J, and Lundgren B.
Scand J Infect Dis. 2000;32(5):481-483. abstract
9 The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection. Katzenstein TL, Kirk O, Pedersen C, Lundgren JD, Nielsen H, Obel N, Nielsen C, Mathiesen LR, and Gerstoft J
J Infect Dis. 2000;182(3):744-750. abstract
10 Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. Kirk O, Gatell JM, Mocroft A, Pedersen C, Proenca R, Brettle RP, Barton SE, Sudre P, and Phillips AN and Lundgren JD for the EuroSIDA Study Group
Am J Respir Crit Care Med. 2000;162(3 Pt 1):865-872. abstract
11 [The Society of Theoretical and Applied Therapy.´The medal of honour for the year of 2000]. Lundgren JD
Ugeskr Laeger. 2000;162(47):6424- abstract
12 [Atovaquone/proguanil. Prophylaxis and treatment of malaria]. Lundgren JD and Dragsted UB
Ugeskr Laeger. 2000;162(31):4177-4181. abstract
13 AIDS across Europe, 1994-98: the EuroSIDA study. Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, and Lundgren JD for the EuroSIDA Study Group
Lancet. 2000;356(9226):291-296. abstract
14 Virological failure among patients on HAART from across Europe: results from the EuroSIDA study. Mocroft A, Miller V, Chiesi A, Blaxhult A, Katlama C, Clotet B, Barton S, and Lundgren JD
Antivir Ther. 2000;5(2):107-112. abstract
15 Use of medical chemoprophylaxis and antimosquito precautions in Danish malaria patients and their traveling companions. Mølle I, Christensen KL, Hansen PS, Dragsted UB, Aarup M, and Buhl MR
J Travel Med. 2000;7(5):253-258. abstract
16 Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Østergaard C, Yieng-Kow RV, Larsen CG, Mukaida N, Matsushima K, Benfield T, Frimodt-Moller N, Espersen F, Kharazmi A, and Lundgren JD
Clin Exp Immunol. 2000;122(2):207-211. abstract
17 Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Østergaard C, Yieng-Kow RV, Benfield T, Frimodt-Moller N, Espersen F, and Lundgren JD
Infect Immun. 2000;68(6):3153-3157. abstract
18 Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Paredes R, Mocroft A, Kirk O, Lazzarin A, Barton SE, van Lunzen J, Katzenstein TL, Antunes F, Lundgren JD, and Clotet B for the EuroSIDA Study Group
Arch Intern Med. 2000;160(8):1123-1132. abstract
19 Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Sidenius N, Sier CFM, Ullum H, Pedersen BK, Lepri AC, Blasi F, and Eugen-Olsen J
Blood. 2000;96(13):4091-4095. abstract
Updated: 13 Dec 2005
|
|
|
|